左心室肥厚患者的血浆代谢物及代谢途径的变化  

Changes of plasma metabolites and metabolic pathways in patients with left ventricular hypertrophy

作　　者：高婷 杨晓敏[2,3] 曹荣 岳建伟 GAO Ting;YANG Xiaomin;CAO Rong;YUE Jianwei(2020 Graduate Students of Baotou Medical College,Inner Mongolia University of Science and Technology,Baotou 014040,China;Department of Cardiology,the Second Affiliated Hospital of Baotou Medical College,Inner Mongolia University of Science and Technology,Institute of Hypertension,Inner Mongolia Autonomous Region;General Practice Department of Sir Run Run Shaw Hospital,Zhejiang University School of Medicine)

机构地区：[1]内蒙古科技大学包头医学院,内蒙古包头014040 [2]内蒙古科技大学包头医学院第二附属医院心内科,内蒙古自治区高血压研究所 [3]浙江大学医学院附属邵逸夫医院全科

出　　处：《包头医学院学报》2024年第12期37-42,共6页Journal of Baotou Medical College

基　　金：内蒙古自治区科技创新引导项目(CXYD2021BT04);吴阶平医学基金临床研究专项资金(320.6750.19089-90)。

摘　　要：目的:探讨高血压伴或不伴左心室肥厚(LVH)与健康人群的代谢变化以及可能影响的代谢途径。方法:招募高血压(HTN)患者30名(HTN组)、高血压伴LVH患者30名(LVH组)和健康志愿者30名(对照组),使用非靶向代谢组学方法获得血浆样本的代谢物谱。结果:共检测到1141个代谢物,有43个显著性差异代谢物仅在LVH组与对照组中发生变化,如亮氨酸、腺嘌呤、厚朴酚等,且LVH患者亮氨酸以及腺嘌呤上调。通过KEGG通路分析,共有22种差异代谢产物参与了LVH的代谢途径,与HTN组相比,LVH组亚油酸代谢以及α-亚麻酸(α-linolenic acid,ALA)代谢通路下调。结论:与健康人相比,LVH患者的代谢物谱有显著不同,表明心肌脂肪酸可能是LVH的保护因素,亮氨酸、腺嘌呤可能是LVH的危险因素,通过α-亚麻酸代谢途径可改善LVH。Objective:To investigate the metabolic changes and possible metabolic pathways of hypertension with or without left ventricular hypertrophy(LVH)and healthy people.Methods:Thirty patients with hypertension(HTN)(HTN group),30 patients with hypertension and LVH(LVH group)and 30 healthy volunteers(control group)were recruited.The metabolic profiles of plasma samples were obtained by non-targeted metabolomics.Results:A total of 1141 metabolites were detected,of which 43 were significantly different only in LVH group and control group,such as leucine,adenine,magnolol and so on.Leucine and adenine were up-regulated in LVH patients.According to the analysis of KEGG pathway,a total of 22 differential metabolites were involved in the metabolic pathway of LVH.Compared with HTN group,linoleic acid metabolism andα-linolenic acid(α-linolenicacid,ALA)metabolic pathway were down-regulated in LVH group.Conclusion:Compared with healthy subjects,the metabolic spectrum of patients with LVH is significantly different,indicating that myocardial fatty acids may be protective factors of LVH,leucine and adenine may be risk factors of LVH,and LVH can be improved byα-linolenic acid metabolic pathway.

关 键 词：高血压 高血压伴左心室肥厚 非靶向代谢组学 

分 类 号：R541[医药卫生—心血管疾病]